<DOC>
	<DOCNO>NCT00328965</DOCNO>
	<brief_summary>This study design evaluate anti-hypertensive efficacy lacidipine hypertensive Type 2 diabetes effectiveness endothelial cell function Korean population .</brief_summary>
	<brief_title>Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Lacidipine</mesh_term>
	<criteria>Inclusion criterion : Newly diagnose essential hypertension treat past 2 week ( If subject take medication past 2 week , washout period least 2 week complete prior perform screening ( week 2 ) assessment ) Mean seat SBP screen visit = 130mmHg ( measured mercury sphygmomanometer ) Type 2 diabetes ( American Diabetes Association criterion 2004 ) HbA1C &lt; 11 % Agree practice acceptable contraceptive measure study , 30 day last dose study medication take subject female childbearing potential Provide write informed consent Exclusion criterion : Mean seat SBP &gt; 180 mmHg Known suspect secondary hypertension Anemia define haemoglobin concentration &lt; 10.0 g/dL Hemoglobinopathy peripheral vascular disease Clinically significant renal hepatic disease ( i.e. , subject serum creatinine = 2.0 mg/dL ; Alanine aminotransferase , Aspartate aminotransferase , total bilirubin , alkaline phosphatase &gt; 2.5 time upper limit normal reference range ) Unstable severe angina , coronary insufficiency , congestive heart failure require pharmacologic treatment Chronic disease require intermittent chronic treatment oral , intravenous , intraarticular corticosteroid ( i.e . use topical , inhaled nasal corticosteroid permissible ) Female lactating , pregnant , plan become pregnant clinically significant abnormality identify screen judgement investigator make subject unsuitable inclusion study ( e.g . physical examination , laboratory test , electrocardiogram etc . ) Acute chronic metabolic acidosis history diabetic ketoacidosis</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Korean patient</keyword>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Endothelial function</keyword>
	<keyword>lacidipine</keyword>
	<keyword>Essential hypertension</keyword>
</DOC>